Company Filing History:
Years Active: 2006-2008
Title: Berkley Lynch: Innovator in Neurological Research
Introduction
Berkley Lynch is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of neurological research. With a focus on the characterization of synaptic vesicle proteins, her work has led to advancements in understanding and treating various neurological conditions.
Latest Patents
Berkley Lynch holds two patents that highlight her innovative approaches. The first patent involves methods for identifying agents that bind to a levetiracetam binding site (LBS) or compete with levetiracetam binding to a synaptic vesicle protein 2 (SV2). This invention includes methods for characterizing the properties and functions of SV2 proteins, as well as identifying compounds that modulate the activity of these proteins. The second patent focuses on methods for identifying agents for the treatment of seizures, neurological diseases, endocrinopathies, and hormonal diseases. This patent also emphasizes the characterization of SV2 proteins and the identification of compounds that influence their binding with levetiracetam.
Career Highlights
Berkley Lynch has established herself as a key figure in her field through her innovative research and patent contributions. Her work at UCB S.A. has positioned her at the forefront of neurological research, where she continues to explore the complexities of synaptic vesicle proteins and their implications for treatment.
Collaborations
Berkley has collaborated with notable colleagues, including Karl Nocka and Bruno Fuks, to further her research and enhance the impact of her inventions.
Conclusion
Berkley Lynch's contributions to neurological research through her patents and collaborative efforts underscore her role as an influential inventor in the field. Her work continues to pave the way for advancements in the treatment of neurological disorders.